Mitochondria and Metabolic Syndrome in a Southern California Chinese Cohort



Status:Completed
Conditions:Endocrine, Diabetes
Therapuetic Areas:Endocrinology
Healthy:No
Age Range:Any
Updated:4/21/2016
Start Date:November 2006
End Date:August 2010

Use our guide to learn which trials are right for you!

Diffuse Optical Spectroscopy Measurement Technique is Helping Develop More Effective Diagnostic Tools and Therapeutic Regimes for Diabetes, Metabolic Syndrome and Other Mitochondrial Diseases Some Time in the Future

There has been increasing support for our hypothesis that mitochondrial dysfunction plays an
important role in the etiology of Type 2 Diabetes Mellitus and the overlapping Metabolic
Syndrome.

Once the mitochondrial defect(s) of these subjects has been defined, the data will be used
to develop two non-invasive screening tools to detect mitochondrial defects in Diabetes
Mellitus and Metabolic Syndrome patients.

The device call Diffuse Optical Spectroscopy develope at Beckman Laser Instituteis is
non-invasive measurement technique, to measure the properties of the muscle tisuue and
vascular activity (calf, bicep, or the brain)to evaluate the patient's metabolic status and
and to assess muscle mitochondrial OXPHOS function.

Inclusion Criteria:

- Chinese descent and have been clinically diagnosed with diabetes mellitus (DM) or
have met the study criteria for metabolic syndrome (MS).

Exclusion Criteria:

- non chiness descent
We found this trial at
1
site
Irvine, California 92612
?
mi
from
Irvine, CA
Click here to add this to my saved trials